Inhalation and nasal drug delivery devices are pharmaceutical technologies designed to administer medications directly to the respiratory system through inhalation or nasal routes. These devices include inhalers, nebulizers, nasal sprays, and nasal inhalers, each tailored to deliver specific types of medications such as bronchodilators, corticosteroids, antihistamines, or decongestants. Inhalation devices are commonly used to treat respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis, delivering drugs directly to the lungs for rapid absorption and localized therapeutic effects. Nasal drug delivery devices, on the other hand, are used to administer medications to the nasal mucosa for the treatment of allergies, sinusitis, nasal congestion, or systemic conditions. These devices offer advantages such as targeted drug delivery, fast onset of action, reduced systemic side effects, and improved patient compliance, making them valuable tools in the management of respiratory and nasal diseases.
The global Inhalation and Nasal Drug Delivery Devices market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Inhalation and Nasal Drug Delivery Devices market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Inhalation and Nasal Drug Delivery Devices market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Inhalation and Nasal Drug Delivery Devices market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Inhalation and Nasal Drug Delivery Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Inhalation and Nasal Drug Delivery Devices market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Inhalation and Nasal Drug Delivery Devices
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Inhalation and Nasal Drug Delivery Devices market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GlaxoSmithKline (GSK), AstraZeneca, Boehringer Ingelheim, Viatris, Merck, Novartis, AptarGroup, Chiesi Farmaceutici, Koninklijke Philips, Teva Pharmaceutical Industries, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Inhalation and Nasal Drug Delivery Devices market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Metered- dose Inhalers
Dry-powder Inhalers
Nebulizers
麻豆原创 segment by Application
Asthma
Chronic Obstructive Pulmonary Disease (COPD)
Cystic Fibrosis (CF)
Idiopathic Pulmonary Fibrosis (IPF)
Others
Major players covered
GlaxoSmithKline (GSK)
AstraZeneca
Boehringer Ingelheim
Viatris
Merck
Novartis
AptarGroup
Chiesi Farmaceutici
Koninklijke Philips
Teva Pharmaceutical Industries
Monaghan Medical
OMRON
PARI International
Vectura
H&T Presspart
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Inhalation and Nasal Drug Delivery Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Inhalation and Nasal Drug Delivery Devices, with price, sales quantity, revenue, and global market share of Inhalation and Nasal Drug Delivery Devices from 2019 to 2024.
Chapter 3, the Inhalation and Nasal Drug Delivery Devices competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Inhalation and Nasal Drug Delivery Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Inhalation and Nasal Drug Delivery Devices market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Inhalation and Nasal Drug Delivery Devices.
Chapter 14 and 15, to describe Inhalation and Nasal Drug Delivery Devices sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Inhalation and Nasal Drug Delivery Devices Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Metered- dose Inhalers
1.3.3 Dry-powder Inhalers
1.3.4 Nebulizers
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Inhalation and Nasal Drug Delivery Devices Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Asthma
1.4.3 Chronic Obstructive Pulmonary Disease (COPD)
1.4.4 Cystic Fibrosis (CF)
1.4.5 Idiopathic Pulmonary Fibrosis (IPF)
1.4.6 Others
1.5 Global Inhalation and Nasal Drug Delivery Devices 麻豆原创 Size & Forecast
1.5.1 Global Inhalation and Nasal Drug Delivery Devices Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Inhalation and Nasal Drug Delivery Devices Sales Quantity (2019-2030)
1.5.3 Global Inhalation and Nasal Drug Delivery Devices Average Price (2019-2030)
2 Manufacturers Profiles
2.1 GlaxoSmithKline (GSK)
2.1.1 GlaxoSmithKline (GSK) Details
2.1.2 GlaxoSmithKline (GSK) Major Business
2.1.3 GlaxoSmithKline (GSK) Inhalation and Nasal Drug Delivery Devices Product and Services
2.1.4 GlaxoSmithKline (GSK) Inhalation and Nasal Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 GlaxoSmithKline (GSK) Recent Developments/Updates
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca Inhalation and Nasal Drug Delivery Devices Product and Services
2.2.4 AstraZeneca Inhalation and Nasal Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 AstraZeneca Recent Developments/Updates
2.3 Boehringer Ingelheim
2.3.1 Boehringer Ingelheim Details
2.3.2 Boehringer Ingelheim Major Business
2.3.3 Boehringer Ingelheim Inhalation and Nasal Drug Delivery Devices Product and Services
2.3.4 Boehringer Ingelheim Inhalation and Nasal Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Boehringer Ingelheim Recent Developments/Updates
2.4 Viatris
2.4.1 Viatris Details
2.4.2 Viatris Major Business
2.4.3 Viatris Inhalation and Nasal Drug Delivery Devices Product and Services
2.4.4 Viatris Inhalation and Nasal Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Viatris Recent Developments/Updates
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business
2.5.3 Merck Inhalation and Nasal Drug Delivery Devices Product and Services
2.5.4 Merck Inhalation and Nasal Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Merck Recent Developments/Updates
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Inhalation and Nasal Drug Delivery Devices Product and Services
2.6.4 Novartis Inhalation and Nasal Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Novartis Recent Developments/Updates
2.7 AptarGroup
2.7.1 AptarGroup Details
2.7.2 AptarGroup Major Business
2.7.3 AptarGroup Inhalation and Nasal Drug Delivery Devices Product and Services
2.7.4 AptarGroup Inhalation and Nasal Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 AptarGroup Recent Developments/Updates
2.8 Chiesi Farmaceutici
2.8.1 Chiesi Farmaceutici Details
2.8.2 Chiesi Farmaceutici Major Business
2.8.3 Chiesi Farmaceutici Inhalation and Nasal Drug Delivery Devices Product and Services
2.8.4 Chiesi Farmaceutici Inhalation and Nasal Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 Chiesi Farmaceutici Recent Developments/Updates
2.9 Koninklijke Philips
2.9.1 Koninklijke Philips Details
2.9.2 Koninklijke Philips Major Business
2.9.3 Koninklijke Philips Inhalation and Nasal Drug Delivery Devices Product and Services
2.9.4 Koninklijke Philips Inhalation and Nasal Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 Koninklijke Philips Recent Developments/Updates
2.10 Teva Pharmaceutical Industries
2.10.1 Teva Pharmaceutical Industries Details
2.10.2 Teva Pharmaceutical Industries Major Business
2.10.3 Teva Pharmaceutical Industries Inhalation and Nasal Drug Delivery Devices Product and Services
2.10.4 Teva Pharmaceutical Industries Inhalation and Nasal Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 Teva Pharmaceutical Industries Recent Developments/Updates
2.11 Monaghan Medical
2.11.1 Monaghan Medical Details
2.11.2 Monaghan Medical Major Business
2.11.3 Monaghan Medical Inhalation and Nasal Drug Delivery Devices Product and Services
2.11.4 Monaghan Medical Inhalation and Nasal Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.11.5 Monaghan Medical Recent Developments/Updates
2.12 OMRON
2.12.1 OMRON Details
2.12.2 OMRON Major Business
2.12.3 OMRON Inhalation and Nasal Drug Delivery Devices Product and Services
2.12.4 OMRON Inhalation and Nasal Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.12.5 OMRON Recent Developments/Updates
2.13 PARI International
2.13.1 PARI International Details
2.13.2 PARI International Major Business
2.13.3 PARI International Inhalation and Nasal Drug Delivery Devices Product and Services
2.13.4 PARI International Inhalation and Nasal Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.13.5 PARI International Recent Developments/Updates
2.14 Vectura
2.14.1 Vectura Details
2.14.2 Vectura Major Business
2.14.3 Vectura Inhalation and Nasal Drug Delivery Devices Product and Services
2.14.4 Vectura Inhalation and Nasal Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.14.5 Vectura Recent Developments/Updates
2.15 H&T Presspart
2.15.1 H&T Presspart Details
2.15.2 H&T Presspart Major Business
2.15.3 H&T Presspart Inhalation and Nasal Drug Delivery Devices Product and Services
2.15.4 H&T Presspart Inhalation and Nasal Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.15.5 H&T Presspart Recent Developments/Updates
3 Competitive Environment: Inhalation and Nasal Drug Delivery Devices by Manufacturer
3.1 Global Inhalation and Nasal Drug Delivery Devices Sales Quantity by Manufacturer (2019-2024)
3.2 Global Inhalation and Nasal Drug Delivery Devices Revenue by Manufacturer (2019-2024)
3.3 Global Inhalation and Nasal Drug Delivery Devices Average Price by Manufacturer (2019-2024)
3.4 麻豆原创 Share Analysis (2023)
3.4.1 Producer Shipments of Inhalation and Nasal Drug Delivery Devices by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2023
3.4.2 Top 3 Inhalation and Nasal Drug Delivery Devices Manufacturer 麻豆原创 Share in 2023
3.4.3 Top 6 Inhalation and Nasal Drug Delivery Devices Manufacturer 麻豆原创 Share in 2023
3.5 Inhalation and Nasal Drug Delivery Devices 麻豆原创: Overall Company Footprint Analysis
3.5.1 Inhalation and Nasal Drug Delivery Devices 麻豆原创: Region Footprint
3.5.2 Inhalation and Nasal Drug Delivery Devices 麻豆原创: Company Product Type Footprint
3.5.3 Inhalation and Nasal Drug Delivery Devices 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Inhalation and Nasal Drug Delivery Devices 麻豆原创 Size by Region
4.1.1 Global Inhalation and Nasal Drug Delivery Devices Sales Quantity by Region (2019-2030)
4.1.2 Global Inhalation and Nasal Drug Delivery Devices Consumption Value by Region (2019-2030)
4.1.3 Global Inhalation and Nasal Drug Delivery Devices Average Price by Region (2019-2030)
4.2 North America Inhalation and Nasal Drug Delivery Devices Consumption Value (2019-2030)
4.3 Europe Inhalation and Nasal Drug Delivery Devices Consumption Value (2019-2030)
4.4 Asia-Pacific Inhalation and Nasal Drug Delivery Devices Consumption Value (2019-2030)
4.5 South America Inhalation and Nasal Drug Delivery Devices Consumption Value (2019-2030)
4.6 Middle East & Africa Inhalation and Nasal Drug Delivery Devices Consumption Value (2019-2030)
5 麻豆原创 Segment by Type
5.1 Global Inhalation and Nasal Drug Delivery Devices Sales Quantity by Type (2019-2030)
5.2 Global Inhalation and Nasal Drug Delivery Devices Consumption Value by Type (2019-2030)
5.3 Global Inhalation and Nasal Drug Delivery Devices Average Price by Type (2019-2030)
6 麻豆原创 Segment by Application
6.1 Global Inhalation and Nasal Drug Delivery Devices Sales Quantity by Application (2019-2030)
6.2 Global Inhalation and Nasal Drug Delivery Devices Consumption Value by Application (2019-2030)
6.3 Global Inhalation and Nasal Drug Delivery Devices Average Price by Application (2019-2030)
7 North America
7.1 North America Inhalation and Nasal Drug Delivery Devices Sales Quantity by Type (2019-2030)
7.2 North America Inhalation and Nasal Drug Delivery Devices Sales Quantity by Application (2019-2030)
7.3 North America Inhalation and Nasal Drug Delivery Devices 麻豆原创 Size by Country
7.3.1 North America Inhalation and Nasal Drug Delivery Devices Sales Quantity by Country (2019-2030)
7.3.2 North America Inhalation and Nasal Drug Delivery Devices Consumption Value by Country (2019-2030)
7.3.3 United States 麻豆原创 Size and Forecast (2019-2030)
7.3.4 Canada 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Mexico 麻豆原创 Size and Forecast (2019-2030)
8 Europe
8.1 Europe Inhalation and Nasal Drug Delivery Devices Sales Quantity by Type (2019-2030)
8.2 Europe Inhalation and Nasal Drug Delivery Devices Sales Quantity by Application (2019-2030)
8.3 Europe Inhalation and Nasal Drug Delivery Devices 麻豆原创 Size by Country
8.3.1 Europe Inhalation and Nasal Drug Delivery Devices Sales Quantity by Country (2019-2030)
8.3.2 Europe Inhalation and Nasal Drug Delivery Devices Consumption Value by Country (2019-2030)
8.3.3 Germany 麻豆原创 Size and Forecast (2019-2030)
8.3.4 France 麻豆原创 Size and Forecast (2019-2030)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Russia 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Italy 麻豆原创 Size and Forecast (2019-2030)
9 Asia-Pacific
9.1 Asia-Pacific Inhalation and Nasal Drug Delivery Devices Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Inhalation and Nasal Drug Delivery Devices Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Inhalation and Nasal Drug Delivery Devices 麻豆原创 Size by Region
9.3.1 Asia-Pacific Inhalation and Nasal Drug Delivery Devices Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Inhalation and Nasal Drug Delivery Devices Consumption Value by Region (2019-2030)
9.3.3 China 麻豆原创 Size and Forecast (2019-2030)
9.3.4 Japan 麻豆原创 Size and Forecast (2019-2030)
9.3.5 South Korea 麻豆原创 Size and Forecast (2019-2030)
9.3.6 India 麻豆原创 Size and Forecast (2019-2030)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2019-2030)
9.3.8 Australia 麻豆原创 Size and Forecast (2019-2030)
10 South America
10.1 South America Inhalation and Nasal Drug Delivery Devices Sales Quantity by Type (2019-2030)
10.2 South America Inhalation and Nasal Drug Delivery Devices Sales Quantity by Application (2019-2030)
10.3 South America Inhalation and Nasal Drug Delivery Devices 麻豆原创 Size by Country
10.3.1 South America Inhalation and Nasal Drug Delivery Devices Sales Quantity by Country (2019-2030)
10.3.2 South America Inhalation and Nasal Drug Delivery Devices Consumption Value by Country (2019-2030)
10.3.3 Brazil 麻豆原创 Size and Forecast (2019-2030)
10.3.4 Argentina 麻豆原创 Size and Forecast (2019-2030)
11 Middle East & Africa
11.1 Middle East & Africa Inhalation and Nasal Drug Delivery Devices Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Inhalation and Nasal Drug Delivery Devices Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Inhalation and Nasal Drug Delivery Devices 麻豆原创 Size by Country
11.3.1 Middle East & Africa Inhalation and Nasal Drug Delivery Devices Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Inhalation and Nasal Drug Delivery Devices Consumption Value by Country (2019-2030)
11.3.3 Turkey 麻豆原创 Size and Forecast (2019-2030)
11.3.4 Egypt 麻豆原创 Size and Forecast (2019-2030)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2019-2030)
11.3.6 South Africa 麻豆原创 Size and Forecast (2019-2030)
12 麻豆原创 Dynamics
12.1 Inhalation and Nasal Drug Delivery Devices 麻豆原创 Drivers
12.2 Inhalation and Nasal Drug Delivery Devices 麻豆原创 Restraints
12.3 Inhalation and Nasal Drug Delivery Devices Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Inhalation and Nasal Drug Delivery Devices and Key Manufacturers
13.2 Manufacturing Costs Percentage of Inhalation and Nasal Drug Delivery Devices
13.3 Inhalation and Nasal Drug Delivery Devices Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Inhalation and Nasal Drug Delivery Devices Typical Distributors
14.3 Inhalation and Nasal Drug Delivery Devices Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
GlaxoSmithKline (GSK)
AstraZeneca
Boehringer Ingelheim
Viatris
Merck
Novartis
AptarGroup
Chiesi Farmaceutici
Koninklijke Philips
Teva Pharmaceutical Industries
Monaghan Medical
OMRON
PARI International
Vectura
H&T Presspart
听
听
*If Applicable.
